Pancreatic Cancer Research

ResearcherUniversity Hospital Southampton NHS Foundation TrustNo recent work listed

Colin Johnson

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5107413514, A5108789296. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
53
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 8

  1. Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 re… Last author DOI 10.1186/s12885-022-09661-7↗
  2. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment. Last author DOI 10.1007/s11136-019-02233-6↗
  3. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-gluco… Co-author DOI 10.3310/hta22070↗
  4. Pro-migratory and TGF-β-activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8-dependent GTPase switch. Co-author DOI 10.1002/path.4923↗
  5. International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Last author DOI 10.1016/j.pan.2015.10.013↗
  6. Pancreatic cancer. Co-author DOI 10.1038/nrdp.2016.22↗
  7. Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer. Last author DOI 10.1016/j.ijrobp.2015.08.026↗
  8. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Co-author DOI 10.1186/1748-717x-8-44↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hyun Kyoo Yoo · 1 shared paper, 2022 · strength 0.16
  2. Suvina Amin · 1 shared paper, 2022 · strength 0.16
  3. John P. Neoptolemos · 3 shared papers, 2016–2018 · strength 0.15
  4. Joseph M. Herman · 1 shared paper, 2019 · strength 0.10
  5. Amol Kumar Narang · 1 shared paper, 2019 · strength 0.10
  6. Andrew Victor Biankin · 2 shared papers, 2016 · strength 0.10
  7. David Cunningham · 2 shared papers, 2016–2018 · strength 0.09
  8. Jo Tod · 1 shared paper, 2017 · strength 0.06
  9. David Roger Fine · 1 shared paper, 2017 · strength 0.06
  10. Gareth J. Thomas · 1 shared paper, 2017 · strength 0.06
  11. John F. Marshall · 1 shared paper, 2017 · strength 0.06
  12. Rachel Ε. Neale · 1 shared paper, 2016 · strength 0.05
  13. Minoti Vivek Apte · 1 shared paper, 2016 · strength 0.05
  14. Murray Korc · 1 shared paper, 2016 · strength 0.05
  15. Jorg H. Kleeff · 1 shared paper, 2016 · strength 0.05
  16. Margaret A. Tempero · 1 shared paper, 2016 · strength 0.05
  17. Ralph H. Hruban · 1 shared paper, 2016 · strength 0.05
  18. David Arthur Tuveson · 1 shared paper, 2016 · strength 0.05
  19. Carlo La Vecchia · 1 shared paper, 2016 · strength 0.05
  20. Robert Peter Sutcliffe · 1 shared paper, 2018 · strength 0.05
  21. Paula Ghaneh · 1 shared paper, 2018 · strength 0.05
  22. Brian Ritchie Davidson · 1 shared paper, 2018 · strength 0.05
  23. Dileep N. Lobo · 1 shared paper, 2018 · strength 0.05
  24. Colin J. McKay · 1 shared paper, 2018 · strength 0.05
  25. Andrew Malvern Smith · 1 shared paper, 2018 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.